Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Refractory obsessive compulsive disorder and ECT

B Maletzky1, B McFarland, A Burt

  • 1Department of Psychiatry, Oregon Health Sciences University, Portland 97201.

Convulsive Therapy
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the Analog Device Inc (ADI) MAX30009 Bioimpedance Analog Front End Chip.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2022
Same author

An architectural understanding of natural sway frequencies in trees.

Journal of the Royal Society, Interface·2019
Same author

Weighing trees with lasers: advances, challenges and opportunities.

Interface focus·2018
Same author

Dispersion of positron emitting radioactive gases in a complex urban building array: a comparison of dose modelling approaches.

Journal of radiological protection : official journal of the Society for Radiological Protection·2016
Same author

Genetic variation in the HLA region is associated with susceptibility to herpes zoster.

Genes and immunity·2014
Same author

Transformation of mercury at the bottom of the Arctic food web: an overlooked puzzle in the mercury exposure narrative.

Environmental science & technology·2014

Electroconvulsive therapy (ECT) effectively treated obsessive compulsive disorder (OCD) in patients unresponsive to other therapies, with sustained improvement for up to one year. Symptom reduction was independent of mood changes.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Obsessive compulsive disorder (OCD) is a debilitating mental health condition.
  • Standard treatments including behavioral therapy, cognitive therapy, and pharmacotherapy are not always effective.
  • Refractory OCD cases require exploration of alternative therapeutic interventions.

Purpose of the Study:

  • To evaluate the efficacy of electroconvulsive therapy (ECT) for patients with treatment-resistant obsessive compulsive disorder (OCD).
  • To assess the long-term effectiveness and duration of symptom improvement following ECT.
  • To determine the relationship between OCD symptom changes and depression levels post-ECT.

Main Methods:

  • A retrospective review of 32 patients diagnosed with obsessive compulsive disorder (OCD) according to DSM-IIIR criteria.

Related Experiment Videos

  • Patients had previously undergone extensive behavioral, cognitive, and pharmacological treatments without significant benefit.
  • Electroconvulsive therapy (ECT) was administered, and outcomes were assessed for obsessive compulsive symptoms and depression.

    • Main Results:

    • A significant improvement in obsessive compulsive symptoms was observed in most patients following ECT.
    • Sustained symptom improvement was noted for up to one year after the completion of ECT.
    • Some patients experienced short-term improvements in depressive symptoms, but these changes were not directly correlated with OCD symptom improvement.

    Conclusions:

    • Electroconvulsive therapy (ECT) can be a viable and effective treatment option for severe, treatment-resistant obsessive compulsive disorder (OCD).
    • The therapeutic benefits of ECT for OCD symptoms appear to be durable, lasting up to a year.
    • ECT's positive impact on OCD symptoms is distinct from its effects on comorbid depressive symptoms.